Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial

REFERENCES

• Hopfer CJ, Mikulich SK, Crowley TJ. Heroin use among adolescents in treatment for substance use disorders. J Am Acad Child Adolesc Psychiatry 2000; 39(10):1316–1323.
   PubMed Web of Science ®Google Scholar
• Hopfer CJ, Khuri E, Crowley TJ, Hooks S. Adolescent heroin use: A review of the descriptive and treatment literature. J Subst Abuse Treat 2002; 23(3):231–237.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, 2003.
   Google Scholar
• Back SE, Payne RA, Simpson AN, Brady KT. Gender and prescription opioids: Findings from the National Survey on Drug Use and Health. Addict Behav 2010; 35:1001–1007.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, 2007.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) Highlights – 2006 National Admissions to Substance Abuse Treatment Services. Rockville, MD: Office of Applied Studies, 2007.
   Google Scholar
• Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, Schein JR, Katz NP. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: A societal perspective. Clin J Pain 2006; 22(8):667–676.
   PubMed Web of Science ®Google Scholar
• Tamayo-Sarver JH, Dawson NV, Cydulka RK, Wigton RS, Baker DW. Variability in emergency physician decision making about prescribing opioid analgesics. Ann Emerg Med 2004; 43(4):483–493.
   PubMed Web of Science ®Google Scholar
• Brady KT, Back SE, Greenfield S. Women and Addiction: A Comprehensive Handbook. New York, NY: Guilford Press, 2009.
   Google Scholar
• Darke S, Ross J, Teesson M, Lynskey M. Health service utilization and benzodiazepine use among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003; 98(8):1129–1135.
   PubMed Web of Science ®Google Scholar
• Hernandez-Avila CA, Rounsaville BJ, Kranzler HR. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 2004; 74(3):265–272.
   PubMed Web of Science ®Google Scholar
• Hser YI, Anglin DA, Booth MW. Sex differences in addict careers. Am J Drug Alcohol Abuse 1987; 13(3):231–251.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Rounsaville BJ, Kleber HD. Ethnic and gender differences among opiate addicts. Int J Addict 1985; 20(8):1143–1162.
   PubMed Web of Science ®Google Scholar
• Randall CR, Roberts JS, Del Boca FK, Carroll KM, Connors GJ, Mattson ME. Telescoping of landmark events associated with drinking: A gender comparison. J Stud Alcohol 1999; 60(2):252–260.
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004; 39(1):1–23.
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007; 90(1):64–71.
   PubMed Web of Science ®Google Scholar
• Green TC, Serrano JMG, Licari A, Budman SH, Butler SF. Women who abuse prescription opioids: Findings from the Addiction Severity Index – Multimedia Version Connect® prescription opioid database. Drug Alcohol Depend 2009; 103(1–2):65–73.
   PubMed Web of Science ®Google Scholar
• Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: Results from a national US survey. Addiction 2008; 103(2):258–268.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002–2004. J Pain 2005; 6(10):662–672.
   PubMed Web of Science ®Google Scholar
• Carise D, Dugosh KL, McLellan AT, Camilleri A, Woody GE, Lynch KG. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry 2007; 164(11):1750–1756.
   PubMed Web of Science ®Google Scholar
• Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse, and dependence on prescription opioids among US adults: Psychiatric, medical, and substance use correlates. Drug Alcohol Depend 2008; 94(1–3):38–47.
   PubMed Web of Science ®Google Scholar
• Back SE, Payne RA, Waldrop AE, Smith A, Reeves S, Brady KT. Prescription opioid aberrant behaviors: A pilot study of sex differences. Clin J Pain 2009; 25(6):477–484.
   PubMed Web of Science ®Google Scholar
• McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 2007; 32(3):562–575.
   PubMed Web of Science ®Google Scholar
• McCabe SE, Teter CJ, Boyd CJ, Knight JR, Wechsler H. Nonmedical use of prescription opioids among U.S. college students: Prevalence and correlates from a national survey. Addict Behav 2005; 30(4):789–805.
   PubMed Web of Science ®Google Scholar
• McCabe SE, Teter CJ, Boyd CJ. Illicit use of prescription pain medication among college students. Drug Alcohol Depend 2005; 77(1):37–47.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. The NSDUH Report: Patterns and Trends in Nonmedical Prescription Pain Reliever Use: 2002 to 2005. Rockville, MD: Office of Applied Studies, 2007.
   Google Scholar
• Boyd CJ, McCabe SE, Teter CJ. Medical and nonmedical use of prescription pain medication use by youth in a Detroit-area public school district. Drug Alcohol Depend 2006; 81(1):37–45.
   PubMed Web of Science ®Google Scholar
• Wu LT, Pilowsky D, Patkar AA. Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend 2008; 94(1–3):1–11.
   PubMed Web of Science ®Google Scholar
• Substance Abuse Mental Health Services Administration. The NSDUH Report: Demographic and Geographic Variations in Injection Drug Use. Rockville, MD: Office of Applied Studies, 2007.
   Google Scholar
• Wu LT, Howard MO. Is inhalant use a risk factor for heroin and injection drug use among adolescents in the United States? Addict Behav 2007; 32(2):265–281.
   PubMed Web of Science ®Google Scholar
• Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005; 24(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):411–418.
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J. Suicide among heroin users: Rates, risk factors and methods. Addiction 2002; 97(11):1383–1394.
   PubMed Web of Science ®Google Scholar
• Darke S, Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 1995; 39(3):231–235.
   PubMed Web of Science ®Google Scholar
• Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse 1999; 34(8):1137–1165.
   PubMed Web of Science ®Google Scholar
• Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, Bilangi R. Buprenorphine tapering schedule and illicit opioid use. Addiction 2009; 104(2):256–265.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Press, 2000.
   Google Scholar
• Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG. Initial evidence for the reliability and validity of a ‘Lite’ version of the Addiction Severity Index. Drug Alcohol Depend 2007; 87(2–3):297–302.
   PubMed Web of Science ®Google Scholar
• Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE. A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther 1988; 43(1):72–78.
   PubMed Web of Science ®Google Scholar
• Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs 2003; 35(2):253–259.
   PubMed Web of Science ®Google Scholar
• Childress AR, McLellan AT, O’Brien CP. Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict 1986; 81(5The Clinical Trials Network: A Decade of Progress (Guest Editor: Edward Nunes)):655–660.
   PubMedGoogle Scholar
• Kaplan RF, Cooney NL, Baker LH, Gillespie RA, Meyer RE, Pomerleau OF. Reactivity to alcohol-related cues: Physiological and subjective responses in alcoholics and nonproblem drinkers. J Stud Alcohol 1985; 46(4):267–272.
   PubMed Web of Science ®Google Scholar
• DiPaula BA, Schwartz R, Montoya ID, Barrett D, Tang C. Heroin detoxification with buprenorphine on an inpatient psychiatric unit. J Subst Abuse Treat 2002; 23(3):163–169.
   PubMed Web of Science ®Google Scholar
• Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence, correlates and treatment seeking. Drug Alcohol Depend 2005; 78(3):309–315.
   PubMed Web of Science ®Google Scholar
• Oreskovich MR, Saxon AJ, Ellis MLK, Malte CA, Reoux JP, Knox PC. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu agonist, buprenorphine, for acute detoxification from heroin. Drug Alcohol Depend 2005; 77(1):71–79.
   PubMed Web of Science ®Google Scholar
• Ponizovsky AM, Grinshpoon A, Margolis A, Cohen R, Rosca P. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine. Addict Behav 2006; 31(11):2002–2013.
   PubMed Web of Science ®Google Scholar
• White R, Alcorn R, Feinmann C. Two methods of community detoxification from opiates: An open-label comparison of lofexidine and buprenorphine. Drug Alcohol Depend 2001; 65(1):77–83.
   PubMed Web of Science ®Google Scholar
• Potter JS, Hennessy G, Borrow JA, Greenfield SF, Weiss RD. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend 2004; 76(2):213–215.
   PubMed Web of Science ®Google Scholar
• Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, Montoys I, Fischman MW, Collins J, McSherry F, Boardman K, Davies DK, O’Brien CP, Ling WL, Kleber H, Herman BHA. Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal. Drug Alcohol Depend 2008;97(1–2):158–168.
   PubMed Web of Science ®Google Scholar
• Compton WM, Cottler LB, Abdallah AB, Phelps DL, Spitznagel EL, Hortone JC. Substance dependence and other psychiatric disorders among drug dependent subjects: Race and gender correlates. Am J Addict 2000; 9(2):113–125.
   PubMed Web of Science ®Google Scholar
• Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am 1999; 22(2):41–52.
   Web of Science ®Google Scholar
• Fox HC, Sinha R. Sex differences in drug-related stress-system changes: Implications for treatment in substance-abusing women. Harv Rev Psychiatry 2009; 17(2):103–119.
   PubMed Web of Science ®Google Scholar